BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6824024)

  • 1. Prognostic significance of the tumor antigen TA-4 in squamous cell carcinoma of the uterine cervix.
    Kato H; Morioka H; Aramaki S; Tamai K; Torigoe T
    Am J Obstet Gynecol; 1983 Feb; 145(3):350-4. PubMed ID: 6824024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization.
    Maruo T; Shibata K; Kimura A; Hoshina M; Mochizuki M
    Cancer; 1985 Jul; 56(2):302-8. PubMed ID: 2408732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor antigen TA-4 of squamous cell carcinoma in patients with cervical cancer].
    Kato H; Morioka H; Aramaki S; Tamai K; Nagaya T; Nagai M; Torigoe T
    Gan No Rinsho; 1984 May; 30(6 Suppl):574-7. PubMed ID: 6748228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of a tumor antigen TA-4 of squamous cell carcinoma in relation to its appearance in the circulation.
    Kato H; Nagaya T; Torigoe T
    Gan; 1984 May; 75(5):433-5. PubMed ID: 6745563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer.
    Kato H; Morioka H; Tsutsui H; Aramaki S; Torigoe T
    Cancer; 1982 Oct; 50(7):1294-6. PubMed ID: 7104971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-antigen TA-4 in the detection of recurrence in cervical squamous cell carcinoma.
    Kato H; Tamai K; Morioka H; Nagai M; Nagaya T; Torigoe T
    Cancer; 1984 Oct; 54(8):1544-6. PubMed ID: 6478396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of squamous cell carcinoma antigen and ovarian carcinoma antigen (CA 125) in patients with benign and malignant diseases of the uterine cervix.
    Gocze PM; Vahrson HW; Freeman DA
    Oncology; 1994; 51(5):430-4. PubMed ID: 8052484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of tumor associated antigen TA-4 in gynecologic tumors].
    Inoue Y; Ueda G; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Nishino T; Saito J; Abe Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):919-22. PubMed ID: 3894536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma antigen in patients with cancer of the uterine cervix.
    Fuith LC; Daxenbichler G
    Gynecol Obstet Invest; 1988; 26(1):77-82. PubMed ID: 3169633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor antigen of human cervical squamous cell carcinoma: correlation of circulating levels with disease progress.
    Kato H; Miyauchi F; Morioka H; Fujino T; Torigoe T
    Cancer; 1979 Feb; 43(2):585-90. PubMed ID: 421183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q; Liu S; Liu H; Zhang J; Guo S; Wang L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric analysis of tumor antigen TA-4 in cervical squamous cells.
    Sasaki K; Nagai M; Kato H; Torigoe T; Nagamine Y; Takahashi M
    Gan; 1984 Aug; 75(8):703-6. PubMed ID: 6386588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous distribution of acidic TA-4 in cervical squamous cell carcinoma: immunohistochemical demonstration with monoclonal antibodies.
    Kato H; Suehiro Y; Morioka H; Torigoe T; Myoga A; Sekiguchi K; Ikeda I
    Jpn J Cancer Res; 1987 Nov; 78(11):1246-50. PubMed ID: 3121560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of determination of squamous cell carcinoma antigen in the follow up of patients with cancer of the uterine cervix].
    Göcze P; Vahrson H
    Orv Hetil; 1992 Dec; 133(50):3191-4. PubMed ID: 1461640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of the assay of squamous cell carcinoma in cancer of the uterine cervix].
    Gosselin P; Cazin JL; Dehaut JP; Sulman C; Baranzelli MC; Demaille MC
    Presse Med; 1987 Oct; 16(34):1677-9. PubMed ID: 2959941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of squamous cell carcinoma antigen in patients with cervical squamous cell carcinoma.
    Senekjian EK; Young JM; Weiser PA; Spencer CE; Magic SE; Herbst AL
    Am J Obstet Gynecol; 1987 Aug; 157(2):433-9. PubMed ID: 3475982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.
    Bae SN; Namkoong SE; Jung JK; Kim CJ; Park JS; Kim JW; Lee JM; Kim SJ
    Gynecol Oncol; 1997 Mar; 64(3):418-24. PubMed ID: 9062143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy.
    Ogino I; Nakayama H; Okamoto N; Kitamura T; Inoue T
    Int J Gynecol Cancer; 2006; 16(3):1094-100. PubMed ID: 16803491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
    Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunomorphological studies of the antigen associated with squamous cell cancer of the human cervix uteri].
    Ievleva ES; Marshutina NV; Ageenko AN; Khmel'nitskaia NG
    Biull Eksp Biol Med; 1992 Mar; 113(3):304-6. PubMed ID: 1421235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.